Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice-Reference-Cited by-同舟云学术

Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice

Published:2020-05-21 Issue:4 Volume:72 Page:714-727
ISSN:0846-5371
Container-title:Canadian Association of Radiologists Journal
language:en
Short-container-title:Can Assoc Radiol J

Author:

Delli Pizzi Andrea¹²^ORCID,Mastrodicasa Domenico³^ORCID,Cianci Roberta²,Serafini Francesco Lorenzo²,Mincuzzi Erica²,Di Fabio Francesca²,Giammarino Alberto²,Mannetta Gianluca²,Basilico Raffaella²,Caulo Massimo¹²

Affiliation:

1. ITAB—Institute of Advanced Biomedical Technologies, “G. d’Annunzio” University, Chieti, Italy

2. Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University, Chieti, Italy

3. Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) is a recently developed classification aiming to improve the standardization of liver imaging assessment in patients at risk of developing hepatocellular carcinoma (HCC). The LI-RADS v2017 implemented new algorithms for ultrasound (US) screening and surveillance, contrast-enhanced US diagnosis and computed tomography/magnetic resonance imaging treatment response assessment. A minor update of LI-RADS was released in 2018 to comply with the American Association for the Study of the Liver Diseases guidance recommendations. The scope of this review is to provide a practical overview of LI-RADS v2018 focused both on the multimodality HCC diagnosis and treatment response assessment.

Publisher

SAGE Publications

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0846537120923982

Reference55 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

3. 2017 Version of LI-RADS for CT and MR Imaging: An Update

4. LI-RADS 2017: An update

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State-of-the-art imaging of hepatocellular carcinoma;Journal of Gastrointestinal Surgery;2024-08

2. Multi-phasic magnetic resonance imaging of hemodynamic interchanges in hepatocarcinogenesis;Egyptian Journal of Radiology and Nuclear Medicine;2023-10-24

3. Current Imaging Diagnosis of Hepatocellular Carcinoma;Cancers;2022-08-18